Stem cells for osteodegenerative diseases: current studies and future outlook

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 zur Nieden NI. Embryonic stem cell therapy for osteo-degenerative disorders. Biotechnol. Interact. 17, 8–14 (2005). •• Excellent reference for using stem cells to study osteodegenerative diseases.
  Google Scholar
• 2 Office of the Surgeon General (US). Bone Health and Osteoporosis: a Report of the Surgeon General. Reports of the Surgeon General, MD, USA (2004 ).
  Google Scholar
• 3 Kanis JA. WHO Technical Report: Assessment of Osteoporosis at the Primary Health-care Level. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK, 66 (2007).
  Google Scholar
• 4 van der Jagt-Willems HC, van Hengel M, Vis M et al. Why do geriatric outpatients have so many moderate and severe vertebral fractures? Exploring prevalence and risk factors. Age Ageing 41(2), 200–206 (2012).
  MedlineGoogle Scholar
• 5 Konan S, Soler A, Haddad FS. Revision hip replacement in patients 55 years of age and younger. Hip Int. 23(2), 162–165 (2013).
  MedlineGoogle Scholar
• 6 Isaksson E, Wang H, Sahlin L et al. Expression of estrogen receptors (α, β) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast 11(4), 295–300 (2002).
  Medline CASGoogle Scholar
• 7 McClung MR, Harris ST, Miller PD et al. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am. J. Med. 126(1), 13–20 (2013).
  Medline CASGoogle Scholar
• 8 Janovská Z. Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy. Acta Medica (Hradec Kralove) 55, 111–115 (2012).
  Medline CASGoogle Scholar
• 9 Anasetti C, Logan BR, Lee SJ et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N. Engl. J. Med. 367(16), 1487–1496 (2012).
  Medline CASGoogle Scholar
• 10 Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
  Medline CASGoogle Scholar
• 11 Seale S, Asakura A, Rudnicki MA. The potential of muscle stem cells. Dev. Cell 1, 333–342 (2001).
  Medline CASGoogle Scholar
• 12 Gaustad KG, Boquest AC, Anderson BE, Gerdes AM, Collas P. Differentiation of human adispose tissue using extracts of rat cardiomyocytes. Biophys. Biochem. Res. Commun. 314, 420–427 (2003).
  Google Scholar
• 13 Fadel L, Viana BR, Tajra Feitosa ML et al. Protocols for obtainment and isolation of two mesenchymal stem cell sources in sheep. Acta Cir. Bras. 26(4), 267–273 (2011).
  MedlineGoogle Scholar
• 14 Utsunomiya H, Uchida S, Sekiya I, Sakai A, Moridera K, Nakamura T. Isolation and characterization of human mesenchymal stem cells derived from shoulder tissues. Am. J. Sport Med. 41, 657–668 (2013).
  MedlineGoogle Scholar
• 15 Chang H, Knothe Tate ML. Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells. Stem Cells Transl. Med. 1, 480–491 (2012).
  Medline CASGoogle Scholar
• 16 Lopez-Garcia C, Klein AM, Simons BD, Winton DJ. Intestinal stem cell replacement follows a pattern of neutral drift. Science 330, 822–825 (2010).
  Medline CASGoogle Scholar
• 17 De Rosa L, De Luca M. Dormant and restless skin stem cells. Nature 489, 215–217 (2012).
  MedlineGoogle Scholar
• 18 Volponi AA, Kawasaki M, Sharpe PT. Adult human gingival epithelial cells as a source for whole tooth bioengineering. J. Dent. Res. 92, 329–334 (2013).
  Medline CASGoogle Scholar
• 19 Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 41, 94–114 (2008).
  MedlineGoogle Scholar
• 20 Lodi D, Iannitti T, Palmieri B. Stem cells in clinical practice: applications and warnings. J. Exp. Clin. Cancer Res. 30, 9–29 (2011). • Useful insight into both the potential and risk of using embryonic stem cells (ESCs) for therapeutics.
  MedlineGoogle Scholar
• 21 Smart N, Riley PR. The stem cell movement. Circ. Res. 102, 1155–1168 (2008).
  Medline CASGoogle Scholar
• 22 Grande DA, Southerland SS, Manji R, Pate DW, Schwartz RE, Lucas PA. Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng. 1(1), 345–353 (1995).
  Medline CASGoogle Scholar
• 23 Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331, 889–895 (1994).
  Medline CASGoogle Scholar
• 24 Knutsen G, Drogset JO, Engebretsen L et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J. Bone Joint Surg. Am. 89, 2105 (2007).
  MedlineGoogle Scholar
• 25 Wakitani S, Okabe T, Horibe S et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J. Tissue Eng. Regen. Med. 5(2), 146–150 (2011).
  MedlineGoogle Scholar
• 26 Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl Acad. Sci. USA 94, 5320–5325 (1997).
  Medline CASGoogle Scholar
• 27 Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006).
  Medline CASGoogle Scholar
• 28 Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 46(3), 704–713 (2002).
  MedlineGoogle Scholar
• 29 García-Álvarez F, Alegre-Aguarón E, Desportes P et al. Chondrogenic differentiation in femoral bone marrow-derived mesenchymal cells (MSC) from elderly patients suffering osteoarthritis or femoral fracture. Arch. Gerontol. Geriat. 52, 239–242 (2011).
  Medline CASGoogle Scholar
• 30 English A, Jones EA, Corscadden D et al. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology 46, 1676–1683 (2007).
  Medline CASGoogle Scholar
• 31 Dudics V, Kunstár A, Kovács J et al. Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis: measurements in a microculture system. Cells Tissues Organs 189, 307–316 (2009).
  Medline CASGoogle Scholar
• 32 Toghraie FS, Chenari N, Gholipour MA et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee 18, 71–75 (2011).
  Medline CASGoogle Scholar
• 33 Diekman BO, Wu CL, Louer CR et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents post-traumatic arthritis. Cell Transplant. 22(8), 1395–1408 (2012).
  MedlineGoogle Scholar
• 34 Koh GY, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 19, 902–907 (2012).
  MedlineGoogle Scholar
• 35 Koh GY, Jo SB, Kwon OR et al. Mesenchymal stem cell injections improve knee osteoarthritis. Arthroscopy 29(4), 748–755 (2013).
  MedlineGoogle Scholar
• 36 NIH Clinical Trials Database. www.clinicaltrials.gov
  Google Scholar
• 37 Osteoarthritis and you. www.cdc.gov/features/osteoarthritisplan
  Google Scholar
• 38 Holt HL, Katz JN. Reichmann WM. Forecasting the burden of advanced knee osteoarthritis over a 20 year period in a cohort of older US adults: impact of obesity Presented at: American College of Rheumatology Annual Scientific Meeting, San Francisco, CA, USA, 25–29 October 2008 (Astract 204).
  Google Scholar
• 39 Roldan M, Macias-Gonzalez M, Garcia R, Tinahones FJ, Martin M. Obesity short circuits stemness gene network in human adipose multipotent stem cells. FASEB J. 25, 4111–4126 (2011).
  Medline CASGoogle Scholar
• 40 Wu CL, Diekman BO, Jain D, Guilak F. Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fad pad: the effects of free fatty acids. Int. J. Obes. (Lond.) 37(8), 1079–1087 (2012).
  Google Scholar
• 41 Heldens GT, Bilaney Davidson EN, Vitters EL, Schreurs BW, Piek E, van den Berg WB. Catabolic factors and osteoarthritis conditioned medium inhibit chondrogenesis of human mesenchymal stem cells. Tissue Eng. 18(1–2), 45–54 (2012).
  Medline CASGoogle Scholar
• 42 Boeuf S, Graf F, Fischer J, Moradi B, Little CB, Richter B. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells. Eur. Cells Mater. 23, 320–332 (2012).
  Medline CASGoogle Scholar
• 43 Aggarwal R, Lu J, Kanji S et al. Human umbilical cord blood-derived CD34⁺ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities. PLoS ONE 7(6), e39365 (2012).
  Medline CASGoogle Scholar
• 44 Singh L, Brennan TA, Kim JH et al. Long-term functional engraftment of mesenchymal progenitor cells in a mouse model of accelerated aging. Stem Cells 31(3), 607–611 (2013).
  Medline CASGoogle Scholar
• 45 Guan M, Yao W, Liu R et al. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat. Med. 18(3), 456–462 (2012).
  Medline CASGoogle Scholar
• 46 Li J, Zhang L, Zhou L. Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis. J. Transl. Med. 10, 102–107 (2012).
  Medline CASGoogle Scholar
• 47 Minguell JJ, Allers C, Lasala GP. Mesenchymal stem cells and the treatment of conditions and diseases: the less glittering side of a conspicuous stem cell for basic research. Stem Cells Dev. 22, 193–203 (2013).
  Medline CASGoogle Scholar
• 48 Wagner W, Horn P, Castoldi M et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 3, e2213 (2008).
  MedlineGoogle Scholar
• 49 Kretlow JD, Jin YQ, Liu W et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol. 9, 60 (2008).
  MedlineGoogle Scholar
• 50 Trounson A. The production and directed differentiation of human embryonic stem cells. Endocr. Rev. 27, 208–219 (2006).
  MedlineGoogle Scholar
• 51 Robertson EJ. Derivation and maintenance of embryonic stem cell cultures. Methods Mol. Biol. 75, 173–184 (1997).
  Medline CASGoogle Scholar
• 52 Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 5391(282), 1145–1147 (1998).
  Google Scholar
• 53 Rodda DJ, Chew J, Lim L. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280(26), 24731–24737 (2005).
  Medline CASGoogle Scholar
• 54 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663–676 (2006).
  Medline CASGoogle Scholar
• 55 Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861–872 (2007).
  Medline CASGoogle Scholar
• 56 Huangfu D, Maehr R, Guo W et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795–797 (2008).
  Medline CASGoogle Scholar
• 57 Hou P, Li Y, Liu C et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341(6146), 651–654 (2013).
  Medline CASGoogle Scholar
• 58 Zhou W, Freed C. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27(11), 2667–2774 (2009).
  Medline CASGoogle Scholar
• 59 Tsukiyama T, Asano R, Kawaguchi T et al. Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system. Genes Cells 16(7), 815–825 (2011).
  Medline CASGoogle Scholar
• 60 Davis RP, Nemes C, Varga E et al. Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system. Differentiation 86(1–2), 30–37 (2013).
  Medline CASGoogle Scholar
• 61 Lin T, Ambasudhan R, Yuan X et al. A chemical platform for improved induction of human iPSCs. Nat. Methods 6(11), 805–808 (2009).
  Medline CASGoogle Scholar
• 62 Judson RL, Greve TS, Parchem RJ et al. MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells. Nat. Struct. Mol. Biol. 20(10), 1227–1235 (2013).
  Medline CASGoogle Scholar
• 63 Egashira T, Yuasa S, Fukuda K. Novel insights into disease modeling using induced pluripotent stem cells. Biol. Pharm. Bull. 36(2), 182–188 (2013). • Thoroughly compiles the various potentials for induced pluripotent stem cells in therapeutics, highlighting the great potential effective drug treatment on a patient-specific basis.
  Medline CASGoogle Scholar
• 64 Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848–855 (2010). • Highlights one of the main problems in using induced pluripotent stem cells.
  Medline CASGoogle Scholar
• 65 Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010).
  Medline CASGoogle Scholar
• 66 Kim K, Zhao R, Doi A et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol. 29, 1117–1119 (2011).
  Medline CASGoogle Scholar
• 67 Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107, 4335–4340 (2010).
  Medline CASGoogle Scholar
• 68 Kattman SJ, Witty AD, Gagliardi M et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8(2), 228–240 (2011).
  Medline CASGoogle Scholar
• 69 Ohnishi H, Oda Y, Aoki T et al. A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 6, 261–271 (2012).
  Medline CASGoogle Scholar
• 70 Feng L, Bronson S, Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J. Cell. Biochem. 109, 643–652 (2010).
  MedlineGoogle Scholar
• 71 Nasu A, Ikeya M, Yamamoto T et al. Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin. PLoS ONE 8(1), e53771 (2013).
  Medline CASGoogle Scholar
• 72 Liu J, Chen W, Zhao Z, Xu H. Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering. Biomaterials 4(32), 7862–7872 (2013).
  Google Scholar
• 73 Xu Y, Liu L, Zhang L et al. Efficient commitment to functional CD34⁺ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. PLoS ONE 7(4), e34321 (2012).
  Medline CASGoogle Scholar
• 74 Jung Y, Bauer G, Nolta JA. Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30(1), 42–47 (2013).
  Google Scholar
• 75 de Peppo GM, Marolt D. Make no bones about it: cells could soon be reprogrammed to grow replacement bones? Expert Opin. Biol. Ther. 14(1), 1–5 (2013).
  MedlineGoogle Scholar
• 76 Kelley JM, Daley GQ. Hematopoietic defects and iPSC disease modeling: lessons learned. Immunol. Lett. 155(1–2), 18–20 (2013).
  Medline CASGoogle Scholar
• 77 Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).
  Medline CASGoogle Scholar
• 78 Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78(12), 7634–7638 (1981).
  Medline CASGoogle Scholar
• 79 Alper J. Geron gets green light for human trial of ES cell-derived product. Nat. Biotechnol. 27, 213–214 (2009).
  Medline CASGoogle Scholar
• 80 Stein R. Stem cells were God’s will, says first recipient of treatment. Washington Post, 15th April (2011).
  Google Scholar
• 81 Chapman AR, Scala CC. Evaluating the first-in-human clinical trial of a human embryonic stem cell-based therapy. Kennedy Inst. Ethics J. 22(3), 243–261 (2012).
  MedlineGoogle Scholar
• 82 Schwartz S, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: preliminary report. Lancet 379(9817), 713–720 (2012).
  Medline CASGoogle Scholar
• 83 Advanced Cell Technology. www.advancedcell.com
  Google Scholar
• 84 zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 17, 18–27 (2003).•• Highlights the promise of using ESCs to regenerate bone.
  Google Scholar
• 85 zur Nieden NI. Embryonic stem cell therapy for osteo-degenerative disorders. Biotechnol. Interactions 17, 8–14 (2005).
  Google Scholar
• 86 Yamane T, Kunisada T, Yamazaki H, Era T, Nakano T, Hayashi SI. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90(9), 3516–3523 (1997).
  Medline CASGoogle Scholar
• 87 Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115(12), 3318–3325 (2005).
  Medline CASGoogle Scholar
• 88 Sovani S, Grogan SP. Osteoarthritis: detection, pathophysiology, and current/future treatment strategies. Orthop. Nurs. 32(1), 25–36 (2013).
  MedlineGoogle Scholar
• 89 zur Nieden NI. Embryonic stem cells for osteo-degenerative diseases. Methods Mol. Biol. 690, 1–30 (2011). •• Provides an excellent source of current protocols and research on ESC use for osteodegenerative disorders.
  Medline CASGoogle Scholar
• 90 Dienelt A, zur Nieden NI. Hyperglycemia impairs skeletogenesis from embryonic stem cells by affecting osteoblast and osteoclast differentiation. Stem Cells Dev. 20, 465–474 (2011).
  Medline CASGoogle Scholar
• 91 Valdimarsdotter G, Mummery C. Functions of the TGF-β superfamily in human embryonic stem cells. APMIS 113, 773–789 (2005).
  MedlineGoogle Scholar
• 92 Morali OG, Jouneau A, McLaughlin KJ, Thiery JP, Larue L. IGF-II promotes mesoderm formation. Dev. Biol. 227, 133–145 (2000).
  Medline CASGoogle Scholar
• 93 Hwang YS, Chung BG, Ortmann D, Hattori N, Moeller HC, Khademhosseini A. Microwell mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc. Natl Acad. Sci. USA 106, 16978–16983 (2009).
  Medline CASGoogle Scholar
• 94 Lu CC, Brennan J, Robertson EJ. From fertilization to gastrulation: axis formation in the mouse embryo. Curr. Opin. Genet. Dev. 11, 384–392 (2001).
  Medline CASGoogle Scholar
• 95 Keller KC, zur Nieden NI. Osteogenesis from pluripotent stem cells: neural crest or mesodermal origin? In: Embryonic Stem Cells – Differentiation and Pluripotent Alternatives, Kallos MS (Ed). InTech, Rijeka, Croatia, 323–348 (2011).
  Google Scholar
• 96 Kurosawa H. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J. Biosci. Bioeng. 103(5), 389–398 (2007).
  Medline CASGoogle Scholar
• 97 Itskovitz-Eldor J, Schuldiner M, Karsenti D et al. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Mol. Med. 6, 88–95 (2000).
  Medline CASGoogle Scholar
• 98 Buttery LD, Bourne S, Xynos JD et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 7, 89–99 (2001).
  Medline CASGoogle Scholar
• 99 Kawaguchi J, Mee PJ, Smith AG. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 36, 758–769 (2005).
  Medline CASGoogle Scholar
• 100 Woll NL, Heaney JD, Bronson SK. Osteogenic nodule formation from single embryonic stem cell-derived progenitors. Stem Cell Dev. 15, 865–879 (2006).
  Medline CASGoogle Scholar
• 101 Bielby RC, Pryce RS, Hench LL, Polak JM. Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with ionic dissolution products of 58 S bioactive sol-gel glass. Tissue Eng. 11, 479–488 (2005).
  Medline CASGoogle Scholar
• 102 zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 17, 18–27 (2003).
  Google Scholar
• 103 Warotayanont R, Frenkel B, Snead ML, Zhou Y. Leucine-rich amelogenic peptide induces osteogenesis by activation of the Wnt pathway. Biochem. Biophys. Res. Commun. 387, 558–563 (2009).
  Medline CASGoogle Scholar
• 104 Arpornmaekilong P, Brown SE, Wang Z, Krebsbach PH. Phenotypic characterization, osteogenic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cell Dev. 18, 1–14 (2009).
  MedlineGoogle Scholar
• 105 Rathjen J, Lake JA, Bettess MD, Washington JM, Chapman G, Rathjen PD. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J. Cell Sci. 112, 601–612 (1999).
  Medline CASGoogle Scholar
• 106 Mummery C, Ward D, van den Brink CE et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J. Anat. 200, 233–242 (2002).
  Medline CASGoogle Scholar
• 107 Hwang YS, Randle WL, Bielby R, Polak JM, Mantalaris A. Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with HepG2-conditioned medium and modulation of the embryoid body formation period: application to skeletal tissue engineering. Tissue Eng. 12, 1381–1392 (2006).
  Medline CASGoogle Scholar
• 108 Lee G, Kim H, Elkabetz Y et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat. Biotechnol. 25(12), 1468–1475 (2007).
  Medline CASGoogle Scholar
• 109 Tian XF, Heng BC, Ge Z et al. Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems. Scand. J. Clin. Lab. Invest. 68, 58–67 (2008).
  Medline CASGoogle Scholar
• 110 Garreta E, Genove E, Borros S, Semino CE. Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold. Tissue Eng. 12, 2215–2227 (2006).
  Medline CASGoogle Scholar
• 111 Kim S, Kim SS, Lee SH et al. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly (D,L-lactic-co-glycolic acid)/hydroxyapatite composite scaffold. Biomaterials 29, 1043–1053 (2008).
  Medline CASGoogle Scholar
• 112 Druml C. Stem cell research: toward greater unity in Europe? Cell 139, 649–651 (2009).
  Medline CASGoogle Scholar
• 113 Dhar D, Hsi-En Ho J. Stem cell research policies around the world. Yale J. Biol. Med. 82(3), 113–115 (2009).
  MedlineGoogle Scholar
• 114 Prescott C. The business of exploiting induced pluripotent stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366, 2323–2328 (2011).
  MedlineGoogle Scholar
• 115 HeinOnline: World’s Largest Image-Based Legal Research Database. http://heinonline.org
  Google Scholar
• 116 Amariglio N, Hirshberg A, Scheithauer BW et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. Trends Mol. Med. 6(2), e1000029 (2009).
  Google Scholar
• 117 Sverdlov ED, Mineev K. Mutation rate in stem cells: an underestimated barrier on the way to therapy. Trends Mol. Med. 19(5), 273–280 (2013).
  Medline CASGoogle Scholar
• 118 Gore A, Li Z, Fung HL et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63–67 (2011).
  Medline CASGoogle Scholar
• 119 Thomas ED, Lochte HL, Cannon JM, Sahler OD, Ferrebee JW. Supralethal whole body irradiation and isologous bone marrow transplantation in man. J. Clin. Invest. 38, 1709–1716 (1959).
  Medline CASGoogle Scholar
• 120 Escobedo-Lucea C, Ayuso-Sacedo A, Xiong C et al. Development of a human extracellular matrix for applications related with stem cells and tissue engineering. Stem Cell Rev. 8(1), 170–183 (2012).
  MedlineGoogle Scholar